Phathom Pharmaceuticals (PHAT) Treasury Shares (2019 - 2026)
Phathom Pharmaceuticals (PHAT) reported Treasury Shares of $19.0 for Q1 2026, down 100.0% year-over-year from $583800.0 in Q1 2025, and down 100.0% quarter-over-quarter from $495124.0 in Q4 2025.
Phathom Pharmaceuticals (PHAT) Treasury Shares (2019 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 8 years of Treasury Shares data on file, last reported at $19.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $19.0, down 100.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.0 (down 100.0% YoY), and the FY2025 annual result was $495124.0, down 79.22% from the prior year.
- Treasury Shares fell to $19.0 in Q1 2026 per PHAT's latest filing, from $495124.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $583800.0 in Q1 2025 and troughed at $19.0 in Q1 2022.
- A 5-year average of $120706.6 and a median of $19.0 in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares sank 100.0% in 2022, then surged 2605815.79% in 2025.
- A 5-year view of Treasury Shares shows it stood at $254437.0 in 2022, then slumped by 99.99% to $19.0 in 2023, then changed by 0.0% to $19.0 in 2024, then surged by 2605815.79% to $495124.0 in 2025, then slumped by 100.0% to $19.0 in 2026.
- Business Quant data shows PHAT's Treasury Shares at $19.0 in Q1 2026, $495124.0 in Q4 2025, and $19.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Phathom Pharmaceuticals | 895.99 Mn | 712.23 Mn | 46.31 Mn | 19.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.00 |
| Mar 31, 2026 | 19.00 |
| Dec 31, 2025 | 495,124.00 |
| Dec 31, 2025 | 495,124.00 |
| Sep 30, 2025 | 19.00 |
| Sep 30, 2025 | 19.00 |
| Jun 30, 2025 | 19.00 |
| Jun 30, 2025 | 19.00 |
| Mar 31, 2025 | 583,800.00 |
| Mar 31, 2025 | 583,800.00 |
| Dec 31, 2024 | 19.00 |
| Dec 31, 2024 | 19.00 |
| Jun 30, 2024 | 19.00 |
| Jun 30, 2024 | 19.00 |
| Dec 31, 2023 | 19.00 |
| Dec 31, 2023 | 19.00 |
| Sep 30, 2023 | 19.00 |
| Sep 30, 2023 | 19.00 |
| Jun 30, 2023 | 19.00 |
| Jun 30, 2023 | 19.00 |